Bioactive fungal polysaccharides as potential functional ingredients in food and nutraceuticals

Current Opinion in Biotechnology

Volumn 26, Issue , 2014, Pages 162-173

  Giavasis, Ioannis ^a  

^a TECHNOLOGICAL EDUCATIONAL INSTITUTE OF LARISSA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AGARICALES; ANTI-INFECTIVE AGENTS; ANTICHOLESTEREMIC AGENTS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; BIOLOGICAL PRODUCTS; BIOPOLYMERS; CARBOHYDRATE SEQUENCE; DIETARY SUPPLEMENTS; FOOD INDUSTRY; FUNCTIONAL FOOD; FUNGAL POLYSACCHARIDES; HEALTH; HUMANS; HYPOGLYCEMIC AGENTS; MOLECULAR SEQUENCE DATA; NEOPLASMS; PREBIOTICS;

EID: 84893571208     PISSN: 09581669     EISSN: 18790429     Source Type: Journal    
DOI: 10.1016/j.copbio.2014.01.010     Document Type: Review

References (79)

1. Giavasis I., Biliaderis C. Microbial polysaccharides. Functional Food Carbohydrates 2006, 167-214. CRC Press. C. Biliaderis, M. Izydorczyk (Eds.).
2. Giavasis I. Production of microbial polysaccharides for use in food. Microbial Production of Food Ingredients, Enzymes and Nutraceuticals 2013, 413-468. Woodhead Publishing. B. McNeil, D. Archer, I. Giavasis, L. Harvey (Eds.).
3. Wasser S.P. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol 2002, 60:258-274.
4. Mizuno M., Nishitani Y. Immunomodulating compounds in Basidiomycetes. J Clin Biochem Nutr 2013, 52:202-207.
5. Cho S.M., Park J.S., Kim K.P., Cha D.Y., Kim H.M., Yoo I.D. Chemical features and purification of immunostimulating polysaccharides from the fruit bodies of Agaricus blazei. Korean J Mycol 1999, 27:170-174.
6. Falch B.H., Espevik T., Ryan L., Stokke B.T. The cytokine stimulating activity of (1→3)-β-d-glucans is dependent on the triple helix conformation. Carbohydr Res 2000, 329:587-596.
7. Zhang Y., Li S., Wang X., Zhang L., Cheung P.C.K. Advances in lentinan: isolation, structure, chain conformation and bioactivities. Food Hydrocoll 2011, 25:196-206.
8. Maji P.K., Sen K.I., Devi K.S.P., Maiti T.K., Sikdar S.R., Islam S.S. Structural elucidation of a biologically active heteroglycan isolated from a hybrid mushroom of Pleurotus florida and Lentinula edodes. Carbohyd Res 2013, 368:22-28.
9. Kim S.W., Hwang H.J., Park J.P., Cho Y.J., Song, Yun J.W. Mycelial growth and exo-biopolymer production by submerged culture of various edible mushrooms under different media. Lett Appl Microbiol 2002, 34:56-61.
10. Giavasis I., Harvey L.M., McNeil B. Scleroglucan. Biopolymers, Vol. 8 2002, 37-60. Wiley-VCH, Verlag GmbH. A. Steinbuchel (Ed.).
11. Tang Y.J., Zhong J.J. Role of oxygen in submerged fermentation of Ganoderma lucidum for production of Ganoderma polysaccharide and ganoderic acid. Enz Microb Technol 2003, 32:478-484.
12. Lee C., Bae J.T., Pyo H.B., Choe T.B., Kim S.W., Hwang H.J., Yun J.W. Submerged culture conditions for the production of mycelial biomass and exopolysaccharides by the edible Basidiomycete Grifola frondosa. Enz Microb Technol 2004, 35:369-376.
13. Yoshino S., Hazama S., Kawaoka T., Kondo H., Oka M. Evidence of Lentinan based on clinical study (review). Biotherapy 2006, 20:403-409.
14. Sullivan R., Smith J.E., Rowan N.J. Medicinal mushrooms and cancer therapy: translating a traditional practice into Western medicine. Perspect Biol Med 2006, 49:159-170.
15. Zhou S., Gao Y., Chan E. Clinical trials for medicinal mushrooms: experience with Ganoderma lucidum (W.Curt.:Fr.) Lloyd (Lingzhi Mushroom). Int J Med Mushr 2005, 7:111-117.
16. Aleem E. β-Glucans and their applications in cancer therapy: focus on human studies. Anti-Cancer Agent Med Chem 2013, 13:709-719.
17. Rondanelli M., Opizzi A., Monteferrario F., Klersy C., Cazzola R., Cestaro B. Beta-glucan- or rice bran-enriched foods: a comparative crossover clinical trial on lipidic pattern in mildly hypercholesterolemic men. Eur J Clinic Nutr 2011, 65:864-871.
18. Thakur M.P., Singh H.K. Mushrooms, their bioactive compounds and medicinal uses: a review. Medic Plants 2013, 5:1-20.
19. Ganeshpurkar A., Rai G., Jain A.P. Medicinal mushrooms: towards a new horizon. Pharmacog Rev 2010, 4:127-135.
20. Bao X.F., Wang X.S., Dong Q., Fang J.N., Li X.Y. Structural features of immunologically active polysaccharides from Ganoderma lucidum. Phytochemistry 2002, 59:175-181.
21. Eo S.K., Kim Y.S., Lee C.K., Han S.S. Possible mode of antiviral acivity of acidic protein bound polysaccharide isolated from Ganoderma lucidum on herpes simplex viruses. J Ethnopharm 2000, 72:475-481.
22. Fujimiya Y., Suzuki Y., Oshiman K., Kobori H., Moriguchi K., Nakashima H., Matumoto Y., Takahara S., Ebina T., Katakura R. Selective tumoricidal effect of soluble proteoglucan extracted from the basidiomycete Agaricus blazei Murill, mediated via the natural killer cell activation and apoptosis. Cancer Immunol Immunother 1998, 46:147-159.
23. Mizuno T. Medicinal properties and clinical effects of culimary-medicinal mushroom Agaricus blazei Murill (Agaricomycetidae). Int J Med Mushrooms 2002, 4:299-312.
24. Tsuchida H, Mizuno M, Taniguchi Y, Ito H, Kawade M, Akasaka K: Glucomannan separated from Agaricus blazei mushroom culture and antitumor agent containing as active ingredient. Japanese Patent 11-080206, 2001.
25. Laroche C., Michaud P. New developments and prospective applications for β(1,3) glucans. Recent Patent Biotechnol 2007, 1:59-73.
26. Ooi V.E.C., Liu F. Immunomodulation and anti-cancer activity of polysaccharide-protein complexes. Curr Med Chem 2000, 7:715-729.
27. Boh B., Berivic M. Grifola frondosa (Diks.:Fr.) S.F Gray: (Maitake mushroom): medicinal properties, active compounds,and biotechnological cultivation. Int J Med Mushrooms 2007, 9:89-108.
28. Hobbs ChR. Medicinal value of Turkey Tail fungus Trametes versicolor (L.:Fr.) Pilát (Aphyllophoromycetideae). Int J Med Mushrooms 2004, 6:195-218.
29. Paulik S., Svrcec Mojisova J., Durove A., Benisek Z., Huska M. The immunomodulatory effect of the soluble fungal glucan (Pleurotus ostreatus) on the delayed hypersensitivity and phagocytic ability of blood leucocytes in mice. J Vet Med 1996, 43:129-135.
30. Zhang M., Cheung P.C.K., Zhang L. Evaluation of mushroom dietary fiber (nonstarch polysaccharides) from sclerotia of Pleurotus tuber-regium (Fries) Singer as a potential antitumor agent. J Agric Food Chem 2001, 49:5059-5062.
31. Bergendiova K., Tibenska E., Majtan J. Pleuran (β-glucan from Pleurotus ostreatus) supplementation, cellular immune response and respiratory tract infections in athletes. Europ J Appl Physiol 2011, 111:2033-2040.
32. Lo H.C., Tsai F.A., Wasser S.P., Yang J.G., Huang B.M. Effects of ingested fruiting bodies, submerged culture biomass, and acidic polysaccharide glucuronoxylomannan of Tremella mesenterica Retz.:Fr. on glycemic responses in normal and diabetic rats. Life Sci 2006, 78:1957-1966.
33. Reshetnikov S.V., Wasser S.P., Nevo E., Duckman I., Tsukor K. Medicinal value of the genus Tremella Pers, (Heterobasidiomycetes). Int J Med Mushr 2000, 2:169-193.
34. Cheng K.C., Demirci A., Catchmark J.M. Pullulan: biosynthesis, production, and applications. Appl Microbiol Biotechnol 2011, 92:29-44.
35. Singh R.S., Gaganpreet K.S., Kennedy J. Pullulan: microbial sources, production and applications. Carbohydr Polymers 2008, 73:515-531.
36. Survase S.A., Saudagar P.S., Bajaj I.B., Singhal R.S. Scleroglucan: fermentative production, downstream processing and applications. Food Technol Biotechnol 2007, 45:107-118.
37. Bluhm C., Deslandes Y., Marchessault R., Perz S., Rinaudo M. Solid-state and solution conformations of scleroglucan. Carbohydr Res 1982, 100:117-130.
38. Thammakiti S., Suphantharika M., Phaesuwan T., Verduyn C. Preparation of spent brewer's yeast β-glucans for potential applications in the food industry. Int J Food Sci Technol 2004, 39:21-29.
39. Waszkiewicz-Robak B. Spent Brewer's yeast and beta-glucans isolated from them as diet components modifying blood lipid metabolism disturbed by an atherogenic Diet. Lipid Metabolism 2013, 261-290. Intech. R.V. Baez (Ed.).
40. Kim S.Y., Song H.J., Lee Y.Y., Cho K.H., Roh Y.K. Biomedical issues of dietary fibre β-glucan. J Korean Med Sci 2006, 21:781-789.
41. Ohno N., Miura T., Miura N.N., Adachi Y., Yadomae T. Structure and biological activities of hypochlorite oxidized zymosan. Carbohydr Polym 2001, 44:339-349.
42. Bohn J.A., BeMiller J.N. (1→3)-β-d-Glucans as biological response modifiers: a review of structure-functional activity relationships. Carbohydr Polym 1995, 28:3-14.
43. Ikekawa T. Beneficial effects of edible and medicinal mushrooms in health care. Int J Med Mushrooms 2001, 3:291-298.
44. Chang S.T., Wasser The role of culinary-medicinal mushrooms on human welfare with a pyramid model for human health. Int J Med Mushr 2012, 14:95-134.
45. Sletmoen M., Stokke B.T. Higher order structure of (1,3)-β-d-glucans and its influence on their biological activities and complexation abilities. Biopolymer 2008, 89:310-321.
46. Kulicke W.M., Lettau A.I., Thielking H. Correlation between immunological activity, molar mass, and molecular structure of different (1→3)-β-d-glucans. Carbohydr Res 1997, 297:135-143.
47. Chan G.C.F., ChanWK, Sze D.M.U. The effects of β-glucan on human immune and cancer cells. J Hematol Oncol 2009, 2:25-36.
48. Lindequist U., Niedermeyer T.H., Jülich W.D. The pharmacological potential of mushrooms. Evid Based Complement Alternat Med 2005, 2:285-299.
49. Vannucci L., Krizan J., Sima P., Stakheev D., Caja F., Rajsilova L., Horak V., Saieh M. Immunostimulatory properties and antitumor activities of glucans. Int J Oncol 2013, 43:357-364.
50. Yuen J.W.M., Gohel M.D.I. Anticancer effects of Ganoderma lucidum: a review of scientific evidence. Nutrit Cancer 2005, 53:11-17.
51. Mahajna J., Dotan N., Zaidman B.-Z., Petrova R.D., Wasser S.P. Pharmacological values of medicinal mushrooms for prostate cancer therapy: the case of Ganoderma lucidum. Nutrit Cancer 2009, 61:16-26.
52. YouYH, Lin Z.B. Protective effects of Ganoderma lucidum polysaccharides peptide on injury of macrophages induced by reactive oxygen species. Acta Pharmacol Sin 2002, 23:789-791.
53. Nie S., Zhang H., Li W., Xie M. Current development of polysaccharides from Ganoderma: isolation, structure and bioactivities. Bioact Carbohydr Diet Fibr 2013, 1:10-20.
54. Firenzuoli F., Gori L., Lombard G. The medicinal mushroom Agaricus blazei Murrill: review of literature and pharmaco-toxicological problems. Evid Based Complem Altern Med 2008, 5:3-15.
55. Sandula J., Kogan G., Kacuracova M., Machova E. Microbial (1→3)-β-d-glucans, their preparation, physichochemical characterization and immunomodulatory activity. Carbohydr Polym 1999, 38:247-253.
56. Asaduzzaman K., Mousumi T. Nutritional and medicinal importance of pleurotus mushrooms: an overview. Food Rev Int 2012, 28:313-329.
57. Mattila P., Suonpaa K., Piironen V. Functional properties of edible mushrooms. Nutr 2000, 16:694-696.
58. van Nevel C.J., Decuypere J.A., Dierick N., Molly K. The influence of Lentinus edodes (Shiitake mushroom) preparations on bacteriological and morphological aspects of the small intestine in piglets. Arch Anim Nutr 2003, 57:399-412.
59. Liang J., Melican D., Cafro L., Palace G., Fisette L., Armstrong R., Patchen M.L. Enhanced clearance of a multiple antibiotic resistant Staphylococcus aureus in rats treated with PGG-glucan is associated with increased leukocyte counts and increased neutrophil oxidative burst activity. Int J Immunopharm 1998, 20:595-614.
60. Hetland G., Sandven P. β-1,3-Glucan reduces growth of Mycobacterium tuberculosis in macrophage cultures. FEMS Immunol Med Microbiol 2002, 33:41-45.
61. Barros L., Cruz T., Baptista P., Estevinho L.M., Ferreira I.C.F.R. Wild and commercial mushrooms as source of nutrients and nutraceuticals. Food Chem Toxicol 2008, 46:2742-2747.
62. Mastromarino P., Petruzziello R., Macchia S., Rieti S., Nicoletti R., Orsi N. Antiviral activity of natural and semisynthetic polysaccharides on early steps of rubella virus infection. J Antimicrob Chemother 1997, 39:339-345.
63. Kakumu S., Ishikawa T., Wakita T., Yoshioka K., Ito Y., Shinagawa T. Effect of sizofiran, a polysaccharide, on interferon gamma, antibody production and lymphocyte proliferation specific for hepatitis-B virus antigen in patients with chronic hepatitis-B. Int J Immunopharm 1991, 13:969-975.
64. Markova N., Kussovski V., Radoucheva T., Dilova K., Georgieva N. Effects of intraperitoneal and intranasal application of Lentinan on cellular response in rats. Int Immunopharm 2002, 2:1641-1645.
65. Sasidhara R., Thirunalasundari T. Antimicrobial activity of mushrooms. Biomedical 2012, 32:455-459.
66. Lakhanpal T.N., Rana M. Medicinal and nutraceutical genetic resources of mushrooms. Plant Genet Resourc 2005, 3:288-303.
67. Chen P.X., Wang S., Nie S., Marcone M. Properties of Cordyceps sinensis: a review. J Funct Food 2013, 5:550-569.
68. Bobek P., Galbavy S. Hypocholesteremic and antiatherogenic effect of oyster mushroom (Pleurotus ostreatus) in rabbits. Nahrung 1999, 43:339-342.
69. Kozarski M., Klaus A., Niksic M., Jakovljevic D., Helsper J.P.F.G., Van Griensven L.J.L.D. Antioxidative and immunomodulating activities of polysaccharide extracts of the medicinal mushrooms Agaricus bisporus, Agaricus brasiliensis, Ganoderma lucidum and Phellinus linteus. Food Chem 2011, 129:1667-1675.
70. Yu-Hong Y., Zhi-Bin L. Protective effects of Ganoderma lucidum polysaccharides peptide on injury of macrophages induced by reactive oxygen species. Acta Pharmacol Sin 2002, 23:787-791.
71. Wasser S.P. Current findings, future trends, and unsolved problems in studies of medicinal mushrooms. Appl Microbiol Biotechnol 2011, 89:1323-1332.
72. Xie J., Zhao J., Hu D.J., Duan J.A., Tang Y.P., Li S.P. Comparison of polysaccharides from two species of Ganoderma. Molecules 2012, 17:740-752.
73. Kim J., Lee S., Bae I.Y., Park H.G., Lee H.G., Lee S. (1-3)(1-6)-β-Glucan-enriched materials from Lentinus edodes mushroom as a high-fibre and low-calorie flour substitute for baked foods. J Sci Food Agric 2011, 91:1915-1919.
74. Kim S.Y., Chung S.I., Nam S.H., Kang M.Y. Cholesterol lowering action and antioxidant status improving efficacy of noodles made from unmarketable oak mushroom (Lentinus edodes) in high cholesterol fed rats. J Korean Soc Appl Biol Chem 2009, 52:207-212.
75. Parab D.N., Dhalagade J.R., Sahoo A.K., Ranvee R.C. Effect of incorporation of mushroom (Pleurotus sajor-caju) powder on quality characteristics of Papad (Indian snack food). Food Compos Anal 2012, 63:866-870.
76. Richu S., Moushumi G., Abhijit G. Phenolics and antioxidant activity of a ready-to-eat snack food prepared from the edible mushroom (Agaricus bisporous). Nutr Food Sci 2009, 39:227-234.
77. Brennan M.A., Derbyshire E., Tiwari B.K., Brennan C.S. Enrichment of extruded snack products with coproducts from chestnut mushroom (Agrocybe aegerita) production: interactions between dietary fiber, physicochemical characteristics, and glycemic load. J Agric Food Chem 2012, 60:4396-4401.
78. Yamanaka D., Liu Y., Motoi M., Ohno N. Royal sun medicinal mushroom, Agaricus brasiliensis Ka21 (Higher Basidiomycetes), as a functional food in humans. Int J Med Mushr 2013, 15:335-343.
79. Okamura-Matsui T., Takemura K., Sera M., Takeno T., Noda H., Fukuda S., Ohsugi M. Characteristics of a cheese-like food produced by fermentation of the mushroom Schizophyllum commune. J Biosci Bioeng 2001, 92:30-32.